Subclinical thyrotoxicosis.
J Indian Med Assoc
;
2006 Oct; 104(10): 596, 598-600
Article
in English
| IMSEAR
| ID: sea-98160
ABSTRACT
Subclinical thyrotoxicosis as a definite entity has been recognised with the development of highly sensitive immunometric TSH assays. The condition is characterised by suppressed TSH in presence of normal T3 and T4. It may be due to exogenous or endogenous causes. The risks may be osteoporosis and atrial fibrillation. Exogenous subclinical thyrotoxicosis must be prevented by optimising laevothyroxine dosage. Endogenous subclinical thyrotoxicosis may or may not be treated depending upon the clinical situation and existing comorbidities.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Osteoporosis
/
Atrial Fibrillation
/
Thyrotoxicosis
/
Humans
/
Thyrotropin
/
Risk Factors
Type of study:
Etiology study
/
Risk factors
Language:
English
Journal:
J Indian Med Assoc
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS